WIRE — In a landmark policy shift, the Women's Tennis Association (WTA) will now require all players to undergo genetic sex testing as a condition of competing on the WTA Tour. WTA announced in a statement that effective Tuesday, the updated eligibility rules mandate a one-time cheek swab, blood, or saliva test to detect the SRY gene—a
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.